GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 25 | 0 | 41 | 183 | 56 |
| Cost of Goods | 17 | N/A | 22 | 123 | 12 |
| Gross Profit | 8 | N/A | 19 | 60 | 44 |
| Operating Expenses | 129 | 101 | 273 | 323 | 130 |
| Operating Income | -104 | -101 | -232 | -140 | -74 |
| Interest Expense | 168 | 197 | 194 | 215 | 256 |
| Other Income | 10 | -73 | 82 | 36 | 24 |
| Pre-tax Income | -262 | -371 | -344 | -319 | -306 |
| Net Income Continuous | -262 | -371 | -344 | -319 | -306 |
| Net Income | $-262 | $-371 | $-344 | $-319 | $-306 |
| EBITDA(a) | $-35 | $20 | $-182 | $-37 | $170 |